VNRX
Income statement / Annual
Last year (2025), VolitionRX Ltd's total revenue was $1.73 M,
an increase of 40.04% from the previous year.
In 2025, VolitionRX Ltd's net income was -$23.36 M.
See VolitionRX Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.73 M |
$1.23 M |
$775.30 K |
$306.39 K |
$90.04 K |
$13.43 K |
$17.10 K |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$639.92 K
|
$542.48 K
|
$309.41 K
|
| Gross Profit |
$1.73 M
|
$1.23 M
|
$775.30 K
|
$306.39 K
|
$90.04 K
|
$13.43 K
|
$17.10 K
|
-$639.92 K
|
-$542.48 K
|
-$309.41 K
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.08 M
|
$14.41 M
|
$19.55 M
|
$15.33 M
|
$13.02 M
|
$14.53 M
|
$10.36 M
|
$10.91 M
|
$8.91 M
|
$6.84 M
|
| General & Administrative Expenses |
$9.46 M
|
$12.72 M
|
$15.91 M
|
$15.35 M
|
$14.08 M
|
$5.47 M
|
$4.52 M
|
$5.78 M
|
$5.36 M
|
$5.43 M
|
| Selling & Marketing Expenses |
$3.92 M
|
$922.60 K
|
$1.01 M
|
$1.05 M
|
$746.11 K
|
$1.07 M
|
$965.71 K
|
$1.17 M
|
$763.41 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.38 M
|
$13.64 M
|
$16.92 M
|
$16.40 M
|
$14.83 M
|
$6.54 M
|
$5.49 M
|
$6.95 M
|
$6.13 M
|
$5.43 M
|
| Other Expenses |
-$516.52 K
|
$212.43 K
|
$292.05 K
|
$348.81 K
|
$574.39 K
|
$187.83 K
|
$211.73 K
|
$37.23 K
|
$349.84 K
|
-$361.33 K
|
| Operating Expenses |
$22.95 M
|
$28.26 M
|
$36.76 M
|
$32.09 M
|
$28.42 M
|
$21.26 M
|
$16.06 M
|
$17.90 M
|
$15.05 M
|
$11.91 M
|
| Cost And Expenses |
$22.95 M
|
$28.26 M
|
$36.76 M
|
$32.09 M
|
$28.42 M
|
$21.26 M
|
$16.06 M
|
$17.90 M
|
$15.05 M
|
$11.91 M
|
| Interest Income |
$600.00
|
$9.95 K
|
$93.32 K
|
$125.27 K
|
$2.73 K
|
$49.50 K
|
$112.37 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.49 M
|
$340.36 K
|
$221.62 K
|
$173.09 K
|
$155.80 K
|
$129.80 K
|
$126.57 K
|
$110.92 K
|
$73.13 K
|
$0.00
|
| Depreciation & Amortization |
$1.22 M
|
$1.34 M
|
$1.41 M
|
$1.19 M
|
$1.15 M
|
$1.04 M
|
$902.41 K
|
$639.92 K
|
$542.48 K
|
$309.41 K
|
| EBITDA |
-$19.80 M |
-$25.58 M |
-$34.04 M |
-$29.24 M |
-$25.69 M |
-$19.23 M |
-$15.07 M |
-$17.26 M |
-$14.15 M |
-$11.60 M |
| EBITDA Ratio |
-11.46
|
-20.74
|
-43.91
|
-95.42
|
-285.32
|
-1431.41
|
-881.5
|
0
|
0
|
0
|
| Operating Income Ratio |
-12.29
|
-21.91
|
-46.42
|
-103.72
|
-314.69
|
-1581.76
|
-938.4
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$2.28 M
|
-$233.02 K
|
$310.62 K
|
$1.18 M
|
$1.34 M
|
$848.52 K
|
-$56.13 K
|
-$110.92 K
|
-$73.13 K
|
$361.33 K
|
| Income Before Tax |
-$23.50 M
|
-$27.26 M
|
-$35.68 M
|
-$30.60 M
|
-$26.99 M
|
-$20.40 M
|
-$16.10 M
|
-$18.01 M
|
-$14.77 M
|
-$11.91 M
|
| Income Before Tax Ratio |
-13.61
|
-22.1
|
-46.02
|
-99.87
|
-299.77
|
-1518.6
|
-941.69
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$110.92 K
|
-$276.71 K
|
$0.00
|
| Net Income |
-$23.36 M
|
-$26.97 M
|
-$35.32 M
|
-$30.27 M
|
-$26.81 M
|
-$20.35 M
|
-$16.10 M
|
-$18.01 M
|
-$14.77 M
|
-$11.91 M
|
| Net Income Ratio |
-13.52
|
-21.86
|
-45.56
|
-98.79
|
-297.82
|
-1515.08
|
-941.69
|
0
|
0
|
0
|
| EPS |
-4.4 |
-6.2 |
-10 |
-11 |
-10.2 |
-9 |
-8.2 |
-11.4 |
-11.2 |
-10.4 |
| EPS Diluted |
-4.4 |
-6.2 |
-10 |
-11 |
-10.2 |
-9 |
-8.2 |
-11.4 |
-11.2 |
-10.4 |
| Weighted Average Shares Out |
$5.34 M
|
$4.33 M
|
$3.56 M
|
$2.77 M
|
$2.63 M
|
$2.26 M
|
$1.96 M
|
$1.57 M
|
$1.32 M
|
$1.15 M
|
| Weighted Average Shares Out Diluted |
$5.34 M
|
$4.33 M
|
$3.56 M
|
$2.77 M
|
$2.63 M
|
$2.26 M
|
$1.96 M
|
$1.57 M
|
$1.32 M
|
$1.15 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
